Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2020
ENANTA PHARM (NASDAQ: ENTA) Delayed: 13.37 +0.71 (5.61%)
Previous Close $12.66    52 Week High $34.49 
Open $12.85    52 Week Low $20.39 
Day High $13.40    P/E N/A 
Day Low $12.65    EPS $-3.18 
Volume 225,467